PSEC 📈 Prospect Capital - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74348T1025
PSEC: Debt, Loans, Equity, Real Estate, Investments
Prospect Capital Corporation is a business development company that specializes in providing financing solutions to middle-market and mature companies. It offers a range of debt and equity investments, including mezzanine finance, later-stage financing, emerging growth capital, and leveraged buyouts, among others.
The company's investment portfolio is diversified across various sectors, including energy, industrials, aerospace, defense, chemicals, and more. It has a particular expertise in the energy and industrial sectors, and invests in companies with EBITDA between $5 million and $150 million, and sales value between $10 million and $500 million per transaction.
In addition to debt and equity investments, Prospect Capital Corporation also makes real estate investments, particularly in multi-family residential properties. It invests in both primary origination and secondary loans/portfolios, and focuses on investing in small-sized and medium-sized private companies rather than large public companies.
The company's investment approach is centered around providing financing solutions to companies in need of capital for various purposes, such as debt financings for private equity sponsors, acquisitions, dividend recapitalizations, growth financings, and bridge loans. It also invests in companies that require cash flow term loans, real estate financings, and investments.
Prospect Capital Corporation primarily invests in the United States and Canada, and has a strong track record of investing across various sectors, including consumer discretionary, information technology, utilities, pipeline, storage, power generation, and distribution, among others.
For more information about Prospect Capital Corporation, please visit their corporate profile at https://www.prospectstreet.com/corporate-profile/.
Additional Sources for PSEC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PSEC Stock Overview
Market Cap in USD | 2,085m |
Sector | Financial Services |
Industry | Asset Management |
GiC Industry | Capital Markets |
TER | 0.00% |
IPO / Inception | 2004-07-27 |
PSEC Stock Ratings
Growth 5y | 12.2% |
Fundamental | -15.4% |
Dividend | 76.7% |
Rel. Performance Sector | -44.8 |
Analysts | 1/5 |
Fair Price Momentum | 4.50 USD |
Fair Price DCF | 23.00 USD |
PSEC Dividends
Dividend Yield 12m | 14.60% |
Yield on Cost 5y | 17.89% |
Annual Growth 5y | 0.00% |
Payout Consistency | 89.05% |
PSEC Growth Ratios
Growth Correlation 3m | -74.8% |
Growth Correlation 12m | -35.2% |
Growth Correlation 5y | 27.5% |
CAGR 5y | 4.11% |
CAGR/Mean DD 5y | 0.30 |
Sharpe Ratio 12m | -0.40 |
Alpha | -32.47 |
Beta | 0.62 |
Volatility | 33.56% |
Current Volume | 3904k |
Average Volume 20d | 5156.6k |
As of December 06, 2024, the stock is trading at USD 4.52 with a total of 3,904,004 shares traded.
Over the past week, the price has changed by -5.44%, over one month by -11.06%, over three months by -10.76% and over the past year by -8.92%.
Neither. Based on ValueRay Fundamental Analyses, Prospect Capital is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -15.37 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSEC as of December 2024 is 4.50. This means that PSEC is currently overvalued and has a potential downside of -0.44%.
Prospect Capital has received a consensus analysts rating of 1.00. Therefor, it is recommend to sell PSEC.
- Strong Buy: 0
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, PSEC Prospect Capital will be worth about 4.9 in December 2025. The stock is currently trading at 4.52. This means that the stock has a potential upside of +7.96%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 4.5 | -0.4% |
Analysts Target Price | 5.8 | 27.2% |
ValueRay Target Price | 4.9 | 8% |